Filing Details

Accession Number:
0000902664-19-002373
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-15 17:25:57
Reporting Period:
2019-05-13
Accepted Time:
2019-05-15 17:25:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
722830 Immunomedics Inc IMMU In Vitro & In Vivo Diagnostic Substances (2835) 611009366
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1633313 Avoro Capital Advisors Llc 110 Greene Street
Suite 800
New York NY 10012
Yes No No Yes
1701815 Behzad Aghazadeh C/O Avoro Capital Advisors Llc
110 Greene Street, Suite 800
New York NY 10012
Yes No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Per Share ("Common Stock") Acquisiton 2019-05-13 500,000 $15.07 18,214,461 No 4 P Indirect See footnotes
Common Stock Acquisiton 2019-05-14 125,000 $15.40 18,339,461 No 4 P Indirect See footnotes
Common Stock Acquisiton 2019-05-15 125,000 $14.95 18,464,461 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
No 4 P Indirect See footnotes
No 4 P Indirect See footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,849 Indirect See footnotes
Footnotes
  1. The securities reported herein are held on behalf of accounts managed by Avoro Capital Advisors LLC (formerly venBio Select Advisor LLC), a Delaware limited liability company (the "Investment Manager") and Avoro Life Sciences Fund LLC (formerly venBio Select Fund LLC), a Delaware limited liability company, a fund managed by the Investment Manager. Behzad Aghazadeh ("Dr. Aghazadeh," and together with the Investment Manager, the "Reporting Persons") serves as the portfolio manager and controlling person of the Investment Manager.
  2. The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
  3. Restricted stock units held by Dr. Aghazadeh.